Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!




January 23 - 25 2015, 12:00 AM - 12:00 AM


February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit



December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter


FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur


FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled


Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled



Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Senator Klobuchar Introduces Legislation to Help Prevent Drug Shortages

Tuesday, February 08, 2011

Senator Amy Klobuchar (D-MN) has introduced S.296, the “Preserving Access to Life-Saving Medications Act.”  This legislation is an important first step in addressing drug shortages that are negatively impacting patients care across America today. 
The legislation primarily focuses on increasing the amount of notification manufacturers must provide to the Food and Drug Administration (FDA) when there is a discontinuation, interruption, or adjustment to the production of a specific drug. The legislation would also require manufacturers in coordination with the FDA, to develop contingency plans if the drug they are producing has the potential to go into shortage.
In a press release introducing this legislation, Senator Klobuchar said, “Physicians, pharmacists and patients are currently among the last to know when an essential drug will no longer be available – that’s not right. This common-sense solution will help set up an early warning system so pharmacists and physicians can prepare in advance and ensure that patients continue to receive the best care possible. As we move forward, it is important that we have better coordination between the pharmaceutical industry, the FDA and health care providers so patients don’t lose access to the medications they depend on.”
While legislation is an important step forward, it is just the first step in a multifaceted approach that is necessary to alleviate the drug shortages facing our patients.
A copy of the legislation and a section by section summary is available on ASA’s Drug Shortage webpage.  

Click here to read a joint press release in support of S.296 released by the conveners of the Drug Shortage Summit.

Click here to read ASA's letter of support for S.296



« Back to Washington Alerts